Raymond James analyst issues UNDERPERFORM recommendation for MSFT on September 23, 2026 01:49PM ET. The previous analyst recommendation was Outperform.MSFT was trading at $500.64 at issue of the analyst recommendation.The...
Wedbush analyst issues NEUTRAL recommendation for MSFT on September 23, 2026 01:49PM ET. The previous analyst recommendation was Neutral.MSFT was trading at $500.64 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for MSFT on September 23, 2026 01:49PM ET. The previous analyst recommendation was Outperform.MSFT was trading at $500.64 at issue of the analyst recommendation.The...
Susquehanna analyst issues NEUTRAL recommendation for MSFT on September 23, 2026 01:49PM ET. The previous analyst recommendation was Positive.MSFT was trading at $500.64 at issue of the analyst recommendation.The overall...
Oppenheimer analyst issues OUTPERFORM recommendation for MDCLF on September 23, 2026 01:53PM ET. MDCLF was trading at $34.39 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
KeyBanc analyst issues OVERWEIGHT recommendation for DRI on September 23, 2026 12:29PM ET. The previous analyst recommendation was Overweight.DRI was trading at $213.35 at issue of the analyst recommendation.The overall...
KeyBanc analyst issues OVERWEIGHT recommendation for AKR on September 23, 2026 12:31PM ET. The previous analyst recommendation was Overweight.AKR was trading at $19.37 at issue of the analyst recommendation.The overall...
Evercore ISI analyst issues OUTPERFORM recommendation for ALT on September 23, 2026 12:00PM ET. The previous analyst recommendation was Outperform.ALT was trading at $3.41 at issue of the analyst recommendation.The...
Lake Street analyst issues BUY recommendation for QNRX on September 23, 2026 12:19PM ET. QNRX was trading at $7.01 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
RBC Capital analyst issues OUTPERFORM recommendation for PATH on September 23, 2026 12:44PM ET. The previous analyst recommendation was Outperform.PATH was trading at $13.25 at issue of the analyst recommendation.The...
